‘Swift’ Vascepa Victory Puts Hikma And Reddy’s In Pole Position

But Analyst Calls Generic Threat ‘Overstated’

 
• By Dean Rudge
  
Appeal_Gavel
Amarin has suggested that appeal action against Vascepa ANDA sponsors is not over yet • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin